Skip to the page

Data / Drug companies / Recordati Industria Chimica E Farmaceutica Spa

Recordati Industria Chimica E Farmaceutica Spa: 16 products in the FDA NDC directory, labeler code 12711

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Recordati Industria Chimica E Farmaceutica Spa (labeler code 12711) lists 16 products in the FDA National Drug Code Directory. By type: 14 drugs for further processing, 2 bulk ingredients. Its main marketing category is drugs for further processing. The newest product started marketing on May 7, 2025.

The request: Watch Recordati Industria Chimica E Farmaceutica Spa (FDA labeler code 12711): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
12711
Products in commercial distribution
16
Packages
16
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
January 1, 1969
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Drugs for further processing1487.5%
Bulk ingredients212.5%

Products by type

TypeProductsShare
Drugs for further processing1487.5%
Bulk ingredients212.5%

Dosage forms

Dosage formProductsShare
Powder16100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Osilodrostat phosphate12711-9500PowderBulk ingredientsMay 7, 2025
Osilodrostat phosphate12711-0145PowderBulk ingredientsMay 7, 2025
Ketorolac tromethamine12711-5990PowderDrugs for further processingJuly 30, 2010
Phenytoin12711-4444PowderDrugs for further processingOctober 1, 2009
Diphenhydramine citrate12711-4350PowderDrugs for further processingFebruary 1, 2007
Acyclovir12711-9744PowderDrugs for further processingJanuary 1, 2007
Flavoxate hcl12711-5522PowderDrugs for further processingJanuary 3, 2005
Papaverine hcl12711-7480PowderDrugs for further processingJune 1, 2001
Acyclovir12711-9755PowderDrugs for further processingJanuary 1, 1993
Pyridoxal-5-phosphate12711-7490PowderDrugs for further processingJanuary 1, 1993
Dobutamine hydrochloride12711-4820PowderDrugs for further processingJanuary 1, 1992
Verapamil hydrochloride12711-9279PowderDrugs for further processingJanuary 1, 1983
Dimenhydrinate12711-4675PowderDrugs for further processingJuly 1, 1982
Phenytoin micronized12711-4445PowderDrugs for further processingJuly 1, 1982
Diphenhydramine hydrochloride12711-4367PowderDrugs for further processingJuly 1, 1980
Phenytoin sodium12711-4466PowderDrugs for further processingJanuary 1, 1969

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.